Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine
- 1 January 2000
- journal article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 37 (1), 56-68
- https://doi.org/10.1016/s0037-1963(00)90030-1
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The contribution of cyclosporine A to the understanding and treatment of autoimmune diseasesTransplantation Proceedings, 1999
- Long-Term Outcome After Marrow Transplantation for Severe Aplastic AnemiaBlood, 1998
- Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working partyBritish Journal of Haematology, 1993
- Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholoneBlood, 1992
- Immunosuppressive Therapy for Aplastic Anemia: Indications, Agents, Mechanisms, and ResultsJournal of Pediatric Hematology/Oncology, 1990
- Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trialBlood, 1985
- Antithoracic duct lymphocyte globulin therapy of severe aplastic anemiaBlood, 1983
- Antithymocyte Globulin Treatment in Patients with Aplastic AnemiaNew England Journal of Medicine, 1983
- Aplastic AnemiaNew England Journal of Medicine, 1982
- Severe Aplastic Anaemia: Correlation of in Vitro Tests with Clinical Response to Immunosuppression in 20 PatientsBritish Journal of Haematology, 1981